This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerveny, K. E.
Right arrow Articles by Gulig, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerveny, K. E.
Right arrow Articles by Gulig, P. A.

 Previous Article  |  Next Article 

Infection and Immunity, November 2002, p. 6251-6262, Vol. 70, No. 11
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.11.6251-6262.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice

Karen E. Cerveny,1 Angelo DePaola,2 Donna H. Duckworth,1 and Paul A. Gulig1*

Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, Florida 32610,1 Gulf Coast Seafood Laboratory, U.S. Food and Drug Administration, Dauphin Island, Alabama 365282

Received 28 January 2002/ Returned for modification 29 March 2002/ Accepted 29 July 2002

Vibrio vulnificus is a gram-negative bacterium that contaminates filter-feeding shellfish such as oysters. After ingestion of contaminated oysters, predisposed people may experience highly lethal septicemia. Contamination of wounds with the bacteria can result in devastating necrotizing fasciitis, which can progress to septicemia. The extremely rapid progression of these diseases can render antibiotic treatment ineffective, and death is a frequent outcome. In this study, we examined the potential use of bacteriophages as therapeutic agents against V. vulnificus in an iron-dextran-treated mouse model of V. vulnificus infection. Mice were injected subcutaneously with 10 times the lethal dose of V. vulnificus and injected intravenously, either simultaneously or at various times after infection, with phages. Treatment of mice with phages could prevent death; systemic disease, as measured by CFU per gram of liver and body temperature; and local disease, as measured by CFU per gram of lesion material and histopathologic analysis. Two different phages were effective against three different V. vulnificus strains with various degrees of virulence, while a third phage that required the presence of seawater to lyse bacteria in vitro was ineffective at treating mice. Optimum protection required that the phages be administered within 3 h of bacterial inoculation at doses as high as 108 PFU. One of the protective phages had a half-life in blood of over 2 h. These results demonstrate that bacteriophages have therapeutic potential for both localized and systemic infections caused by V. vulnificus in animals. This model should be useful in answering basic questions regarding phage therapy.

* Corresponding author. Mailing address: Department of Molecular Genetics and Microbiology, Box 100266, College of Medicine, University of Florida, Gainesville, FL 32610-0266. Phone: (352) 392-0050. Fax: (352) 392-3133. E-mail: gulig{at}ufl.edu.

Editor: J. T. Barbieri

Infection and Immunity, November 2002, p. 6251-6262, Vol. 70, No. 11
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.11.6251-6262.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chhibber, S., Kaur, S., Kumari, S. (2008). Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 57: 1508-1513 [Abstract] [Full Text]  
  • Gill, J. J., Pacan, J. C., Carson, M. E., Leslie, K. E., Griffiths, M. W., Sabour, P. M. (2006). Efficacy and Pharmacokinetics of Bacteriophage Therapy in Treatment of Subclinical Staphylococcus aureus Mastitis in Lactating Dairy Cattle.. Antimicrob. Agents Chemother. 50: 2912-2918 [Abstract] [Full Text]  
  • Huff, W. E., Huff, G. R., Rath, N. C., Donoghue, A. M. (2006). Evaluation of the Influence of Bacteriophage Titer on the Treatment of Colibacillosis in Broiler Chickens. Poult. Sci. 85: 1373-1377 [Abstract] [Full Text]  
  • Wills, Q. F., Kerrigan, C., Soothill, J. S. (2005). Experimental Bacteriophage Protection against Staphylococcus aureus Abscesses in a Rabbit Model. Antimicrob. Agents Chemother. 49: 1220-1221 [Abstract] [Full Text]  
  • Tsai, Y.-H., Hsu, R. W.-W., Huang, K.-C., Chen, C.-H., Cheng, C.-C., Peng, K.-T., Huang, T.-J. (2004). Systemic Vibrio Infection Presenting as Necrotizing Fasciitis and Sepsis. A Series of Thirteen Cases. JBJS 86: 2497-2502 [Abstract] [Full Text]  
  • Thompson, F. L., Iida, T., Swings, J. (2004). Biodiversity of Vibrios. Microbiol. Mol. Biol. Rev. 68: 403-431 [Abstract] [Full Text]  
  • Chibani-Chennoufi, S., Sidoti, J., Bruttin, A., Kutter, E., Sarker, S., Brussow, H. (2004). In Vitro and In Vivo Bacteriolytic Activities of Escherichia coli Phages: Implications for Phage Therapy. Antimicrob. Agents Chemother. 48: 2558-2569 [Abstract] [Full Text]  
  • Atterbury, R. J., Connerton, P. L., Dodd, C. E. R., Rees, C. E. D., Connerton, I. F. (2003). Application of Host-Specific Bacteriophages to the Surface of Chicken Skin Leads to a Reduction in Recovery of Campylobacter jejuni. Appl. Environ. Microbiol. 69: 6302-6306 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»